Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01456234Phase 4Terminated
Phase 4, open-label trial of oseltamivir in influenza (2 arms), sponsored by Trial Management Group. Primary endpoint: Time from symptom onset to Oseltamivir access at Day 1. Started Nov 2011; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01456234.